Document is current

Article History

Received: 4 March 2024

Accepted: 17 December 2024

First Online: 21 December 2024

Declarations

:

: The study’s research methodology, procedures for data collection, and informed consent documentation have undergone ethical review and received approval from the Regional Committee for Medical Research Ethics in Norway (REK) [ ] (id number: 543436) and the Norwegian Agency for Shared Services in Education and Research (SIKT) [ ]. Any modifications to the study protocol will be duly reported and subject to review and approval by the REK committee. Families, practitioners, and leaders sign written consents upon project entry. SPARCK practitioners sign after training, leaders after they have been informed of the study. Consents offer tailored information to participant groups, detailed project involvement, data collection, and pros and cons. Basic information include research rationale, data handling, protection measures, data access rights, and withdrawal options. Eligible parents to the RCT receive written information to discuss with their children, designed for child comprehension. It explains project participation and outcomes if the family agrees or declines. For detailed information regarding the RCT, see Tømmerås et al. [ ].

: Not applicable.

: The authors declare that they have no financial interests. All authors, except RBN, have taken part in the development and/or optimization of SPARCK. If successful, SPARCK will be integrated in the non-commercial intervention portfolio at NUBU and offered free-of-charge to Norwegian public services.